Data from EMC - Curated by Toby Galbraith - Last updated 28 July 2016

Indication(s)

Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in perimenopausal and postmenopausal women.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

CLL

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

Visit CLL

Symptomatic Asthma

69% of asthma patients say that their symptoms restrict their daily activities – find out how to manage uncontrolled symptoms

Visit Symptomatic Asthma

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Meda Pharmaceuticals Ltd

Related Content